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An estimated 14.8 million Americans aged 18 years and older, or approximately 6.7% of the 
adult US population, meet the criteria for major depressive disorder in any given year [1]. 
Women are almost twice as likely as men to report lifetime history of a major depressive 
episode, with their first episode occurring in adolescence through to mid-life [2]. An 
estimated 8–16% of US women aged 18–44 years are affected by depression [2,3]. Existing 
research has found depression to be associated with many adverse conditions throughout 
life, including concurrent psychiatric and substance use disorders, chronic conditions such as 
diabetes, decreased fertility, poor pregnancy outcomes such as preterm delivery or low birth-
weight infants, and impaired maternal functioning and bonding.
Compared with men, women are more likely to visit their physician [101] and frequently 
interact with the healthcare system, especially during reproductive years [102]. However, 
only half of women with depression receive a clinical diagnosis [3], which is often the first 
step to treatment. Studies have shown that women who are younger, non-Hispanic white and 
uninsured are less likely to receive clinical diagnoses [3,4]. These groups are also less likely 
to seek treatment [5] and to receive appropriate treatment when care is sought [6]. Barriers 
to care have been well documented in the literature and include financial constraints such as 
healthcare coverage, fragmented care and stigma [3,7]. Given these constraints, addressing 
barriers in diagnosis and treatment of women with depression must be a multifaceted 
approach.
Addressing financial constraints including lack of healthcare coverage
Lack of health insurance is often a barrier to receiving care for depression. The Affordable 
Care Act (ACA) of 2010 increases access to health insurance coverage through a number of 
provisions, including employer coverage requirements, small business tax credits, refundable 
premium subsidies and health insurance exchanges [103]. Additionally, the ACA’s 
expansion of Medicaid could provide coverage for up to an estimated 10 million currently 
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uninsured women, who may only have healthcare coverage during pregnancy and 
postpartum periods [104]. Inclusion of mental health and substance-use disorder services as 
part of the essential benefits package, incentives to coordinate primary care, mental health 
and addiction services, and elimination of pre-existing condition exclusions may also 
improve access to care among women with depression [103].
“Compared with men, women are more likely to visit their physician and frequently 
interact with the healthcare system, especially during reproductive years. However, 
only half of women with depression receive a clinical diagnosis…”
Improving clinician skills & coordination of care
One approach to reducing barriers is to improve the coordination of care by enhancing 
providers’ knowledge and skills in screening, diagnosis and treatment. Improving skills 
among providers who frequently interact with women, such as obstetricians/gynecologists, 
pediatricians and primary care clinicians, may be especially effective. Provider interest in 
gaining knowledge and skills in this area may differ by specialty and committee opinions of 
their professional organizations. For example, in 2009, the president of the American 
Congress of Obstetrics and Gynecology (ACOG) took on perinatal mental health as a key 
priority area of his tenure. A concurrent survey of randomly sampled ACOG fellows found 
that only a third reported taking a continuing medical education course on postpartum 
mental health [8]. However, those who took the course were more likely to report using 
validated questionnaires to diagnose patients, routinely asking about symptoms and tracking 
women with histories of postpartum psychological disorders than non-course takers [8].
Integrating screening for depression into visits with obstetricians/gynecologists, 
pediatricians and primary care clinicians can improve identification of depression among 
women, but effects on treatment uptake are less positive. For example, studies that have 
evaluated universal screening in these settings among women enrolled in state Healthy Start 
and Medicaid programs, have found no observed changes in treatment usage [9,10]. In these 
studies, women who screened positive during integrated screening received referrals to other 
providers, presenting another barrier to diagnosis and treatment. Much of the existing 
literature has evaluated similar screening and treatment referral models; a 2010 ACOG 
committee opinion found insufficient evidence to support a firm recommendation for 
universal antepartum or postpartum screening [11]. Substantial effort to encourage women 
into care and alleviate barriers by providing outreach, child care, transportation and flexible 
schedules of care, was found to increase treatment among women who had previously 
received integrated depression screening at Women, Infants and Children food subsidy 
programs or county-run Title X family clinics [12]. However, this level of effort is 
unrealistic in clinical practice.
Incorporating both screening and diagnostic assessments, as well as treatment engagement 
strategies within the same visit, is feasible and has the potential to increase treatment rates. 
In a study of primarily Hispanic women, those who screened positive during a perinatal visit 
were immediately given a brief diagnostic assessment that incorporated treatment 
engagement strategies such as an explanation of the diagnosis in culturally congruent, easy-
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to-understand language; 90% of women who received a diagnosis during their perinatal visit 
initiated treatment [13]. Algorithms and guidelines for treatment decisions, phone- and 
internet-based provider support from mental health experts, and referral to on-site care also 
have the potential to improve treatment rates among women who are screened for depression 
[7].
“…research is needed to understand which culture-specific factors influence stigma 
towards depression and its treatment, in order to develop successful initiatives and 
campaigns to reduce stigma as a barrier to diagnosis and treatment.”
Reducing stigma
Stigma has historically surrounded mental illness and remains a complex issue. Existing 
literature indicates that culture-specific factors, such as a greater reliance on social support 
and religion, differential presentation of depressive symptoms, mistrust towards the medical 
community, and fear of legal or child-protective issues, may all influence stigma and 
whether a woman seeks and continues treatment [14]. Reducing stigma may alleviate 
disparities in screening and treatment for depression [14]. However, we do not fully 
understand what effectively reduces stigma. In the past three decades, many initiatives have 
been launched to reduce stigma surrounding mental illness, including the 1980s educational 
campaign Depression Awareness, Recognition and Treatment Program sponsored by the 
NIH, the National Alliance on Mental Illness’ Campaign to End Discrimination and the 
more recent campaign, Depression Is Real. However, one study found that stigma towards 
individuals with mental illness did not change between 1996 and 2006, despite the fact that 
the belief that mental illness has a neurobiological origin has increased [15]. Another study 
found that stigma towards mental health treatment may be declining, as more individuals in 
2001–2003 were willing to seek professional help than individuals in 1990–1992 [16].
Conclusion
The ACA of 2010 may help reduce some of the financial barriers to treatment among 
women due to insurance coverage. However, more work is needed to improve coordination 
of services and integration of both screening and treatment in places where women seek 
care. Additionally, research is needed to understand which culture-specific factors influence 
stigma towards depression and its treatment, in order to develop successful initiatives and 
campaigns to reduce stigma as a barrier to diagnosis and treatment.
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